Source: Annual Congress 2012 - Scores, biomarkers and risk factors in respiratory infections
Disease area: Respiratory critical care, Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
D. Ristic, S. Ristic, I. Marinkovic, I. Veselinovic (Nis, Republic Of Serbia). Influence of lung infection on the course and outcome in patients with stroke. Eur Respir J 2012; 40: Suppl. 56, 2512

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of heart disease in patients hospitalized for an acute exacerbation of COPD: Impact on clinical outcome. A 6 month follow-up study Source: Annual Congress 2011 - COPD management Year: 2011 Influence of statin therapy on clinical symptoms, severity and prognosis in patients with community acquired pneumonia Source: Annual Congress 2008 - Factors related to outcome of community-acquired pneumonia Year: 2008 Influence of the limited lung function to the outcome of the surgical treatment in patients with NSCLC Source: Annual Congress 2003 - Lung function testing for preoperative evaluation in lung cancer patients Year: 2003 Incidence and outcome of lung cancer in patients with chronic respiratory failure Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 The impact of depression in recovery and outcome of patients hospitalized for COPD exacerbation Source: Annual Congress 2011 - Exacerbations and severe chronic respiratory disease: oxygen, rehabilitation, admission to hospital and palliative care Year: 2011 Importance of cardiac biomarkers in the evaluation of acute pulmonary thromboembolism severity, mortality and complicated clinical course Source: Annual Congress 2011 - New insights in management of interstitial and vascular lung diseases Year: 2011 Frequency of thromboembolic events in patients with lung cancer at the time of diagnosis and in the course of disease Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients Year: 2011 Effect of hospital volume on patient outcomes in pleural infection Source: Annual Congress 2012 - Epidemiology of various respiratory diseases Year: 2012 Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer Year: 2012 Clinical impact of steps-count during hospitalization after surgery in lung cancer patients Source: International Congress 2019 – Biology and prognosis of lung cancer Year: 2019 Long-term risks of cardiovascular events in patients with chronic kidney disease who survived sepsis Source: International Congress 2016 – Sepsis and ARDS: looking forward Year: 2016 Impact of COVID-19 on patients with chronic lung disease Source: Virtual Congress 2021 – COVID - 19 epidemiology Year: 2021 The outcome of patients with COPD selected for a lung volume reduction surgery Source: Annual Congress 2009 - Preoperative functional assessment and surgery for malignant diseases Year: 2009 Effect of the type of end-stage lung disease on postoperative evolution of lung transplantation patients Source: Annual Congress 2012 - Optimising outcomes after lung transplantation Year: 2012 Frequency, severity and risk factors of drug-induced liver injury during treatment of new tuberculosis patients Source: Annual Congress 2012 - Tuberculosis: clinical findings III Year: 2012 Effect of exercise and respiratory training on time to clinical worsening and survival in patients with severe chronic pulmonary hypertension Source: Annual Congress 2008 - Medical treatment of pulmonary hypertension Year: 2008 The Influence of first year’s hospitalization on afterward clinical stability and prognosis in long-term NIV patients. Source: International Congress 2019 – Treatment of chronic respiratory failure with noninvasive ventilation Year: 2019 Prevalence of and risk factors for pulmonary complications after lung cancer surgery in elderly patients with preserved lung function Source: International Congress 2018 – Lung cancer: modern therapies and beyond Year: 2018